ARTICLES BY THIS AUTHOR
- 8/31/2010
Editorial: What’s on your horizon?
The forest of opportunity is lush as pharmacy transitions to patient-centred practice. - 8/31/2010
Webinar to cover virtual care delivery
- 8/31/2010
Drug News: Finacea, FluMist, Intanza
Finacea: new topical treatment for rosacea; FluMist: first intranasal flu vaccine; Intanza: first intradermal flu vaccine. - 8/31/2010
Mapping out this year’s pharmacy trends
Our annual Trends & Insights Survey of Retail Pharmacists paints a picture of pharmacy practice amidst volatility. - 8/31/2010
Dealing with grievances under new regulations
With regulation, expected to come soon, techs will be held to the same standards pharmacists are accustomed to and will be accountable to the Ontario College of Pharmacists (OCP). - 8/31/2010
Letter: Questioning the role of DPP-4 inhibitors
A reader comments on the role of DPP-4 inhibitors in the management of type 2 diabetes. - 8/31/2010
Other opportunities enabling expanded scopes of practice
Beyond the provision of prescriptive privileges. - 8/31/2010
No stranger to controversy
Doug Bungay works to optimize the roles and practices of registered nurses, licensed practical nurses, and assistive personnel in Nova Scotia. - 8/31/2010
Research Highlights: Drug-eluting stents - duration of dual antiplatelet therapy
Percutaneous coronary intervention is a procedure used to treat the stenotic coronary arteries found in coronary heart disease.